Disposition pharmacokinetics of bezafibrate in man
โ Scribed by U. Abshagen; W. Bablok; K. Koch; P. D. Lang; H. A. E. Schmidt; M. Senn; H. Stork
- Publisher
- Springer
- Year
- 1979
- Tongue
- English
- Weight
- 955 KB
- Volume
- 16
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The disposition of the b-blocking drug talinolol is controlled by P-glycoprotein in man. Because talinolol is marketed as a racemate, we reevaluated the serum-concentration time proยฎles of talinolol of a previously published study with single intravenous (30 mg) and repeated oral talinolol (100 mg f
The whole blood pharmacokinetics of intravenously administered 99mTc-disofenin (DISIDA) have been studied in dogs. Serial blood sampling permitted calculation of whole blood disposition rates, which principally represent liver clearance. There were striking differences in these rates between 6 norma
The whole blood pharmacokinetics of intravenously administered 99mTc-disofenin (DISIDA) has been studied in normal subjects and patients with documented liver disease. The apparent overall whole blood disposition rates of radioactivity were calculated from serial blood data, in order to evaluate liv